New drugs are approved later in Canada than in the United States and European Union.
New drugs are approved later in Canada than in the United States and European Union.
Regardless of their potential impact on patient health, drug approval times in Canada were longer than in other countries.
Drugs were approved in the U.S. 469 days earlier (on average) than in Canada.
